TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ +0.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENGN
Line item 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0%
– 1.2% 0.4% 98.3% 79.5% 90.9%
– 0.8% 0.2% 93.7% 55.6% 22.6%
– 0.8% 0.2% 93.8% 76.6% 87.5%
– 1.2% 1.0% 2.7% 0.3% 1.0%
– 0.1% 0.1% 0.1% – –
– 3.1% 3.5% 16.6% 12.4% 24.3%
– 0.2% 0.7% 6.0% 4.7% 14.4%
– 0.8% 1.0% 0.6% 0.4% 4.5%
– 0.8% 0.5% 1.3% 0.5% 3.0%
– 2.3% 23.4% 10.6% 7.2% 6.9%
– 96.9% 96.5% 83.4% 87.6% 75.7%
– -1.7% -3.1% -229.5% -81.9% -168.0%
– 12.0% 12.0% 27.1% 14.3% 23.1%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?